(VIANEWS) – Another day of trading has ended and here’s today’s list of stocks that have had significant trading activity in the Euronext session.
The three biggest winners today are BERGENBIO, NHOA, and MEDIA CAPITAL.
| Financial Asset | Price | Change | Updated (EST) |
|---|---|---|---|
| BERGENBIO (BGBIO.OL) | 0.34 | 12.13% | 2024-01-04 12:25:02 |
| NHOA (NHOA.PA) | 0.77 | 10.06% | 2024-01-04 13:20:42 |
| MEDIA CAPITAL (MCP.LS) | 1.12 | 9.8% | 2024-01-04 12:23:34 |
| SAINT JEAN GROUPE (SABE.PA) | 20.80 | 8.9% | 2024-01-04 13:22:11 |
| INNATE PHARMA (IPH.PA) | 2.74 | 8.73% | 2024-01-04 13:05:05 |
| OCEANTEAM (OTS.OL) | 1.45 | 8.65% | 2024-01-04 12:41:46 |
| NANOBIOTIX (NANO.PA) | 7.12 | 7.88% | 2024-01-04 13:20:31 |
| AVANCE GAS HOLDING (AGAS.OL) | 170.00 | 6.92% | 2024-01-04 12:24:53 |
| PLAST.VAL LOIRE (PVL.PA) | 4.12 | 6.74% | 2024-01-04 13:21:28 |
| MEDINCELL (MEDCL.PA) | 7.37 | 6.66% | 2024-01-04 13:20:11 |
The three biggest losers today are CASINO GUICHARD, SCHEERD.V KERCHOVE, and ADOCIA.
| Financial Asset | Price | Change | Updated (EST) |
|---|---|---|---|
| CASINO GUICHARD (CO.PA) | 0.65 | -12.65% | 2024-01-04 13:00:55 |
| SCHEERD.V KERCHOVE (SCHD.BR) | 414.00 | -10% | 2024-01-04 12:21:21 |
| ADOCIA (ADOC.PA) | 10.28 | -8.7% | 2024-01-04 12:44:55 |
| RALLYE (RAL.PA) | 0.12 | -7.91% | 2024-01-04 13:21:43 |
| PIERRE VAC BSA ACT (VACBS.PA) | 0.13 | -7.04% | 2024-01-04 13:21:23 |
| DGB GROUP N.V. (DGB.AS) | 0.47 | -5.1% | 2024-01-04 12:01:33 |
| GEA GRENOBL.ELECT. (GEA.PA) | 95.00 | -5% | 2024-01-04 13:04:06 |
| CNOVA (CNV.PA) | 1.90 | -5% | 2024-01-04 13:01:20 |
| BE SEMICONDUCTOR (BESI.AS) | 124.45 | -4.71% | 2024-01-04 12:00:54 |
| ATOS (ATO.PA) | 6.28 | -4.68% | 2024-01-04 12:45:53 |
Winners today
1. BERGENBIO (BGBIO.OL)
12.13% Price Change
BerGenBio ASA, a clinical-stage biopharmaceutical company, engages in development of novel medicines to treat immune-evasive, drug resistant, and metastatic cancers; and respiratory diseases. It develops bemcentinib, an oral once-a-day inhibitor of AXL receptor tyrosine kinase, which is in Phase 1b/2a clinical trial to treat non-small cell lung cancer, and Phase 2 clinical trial to treat acute myeloid leukemia and COVID-19. Bemcentinib is also being studied for glioblastoma, 2L lung cancer, melanoma, pancreatic cancer, and mesothelioma. In addition, the company is developing tilvestamab, an anti-AXL function-blocking monoclonal antibody that is in Phase 1b clinical trial for the treatment of ovarian cancer; and mipasetamab uzoptirine, which is in Phase 1 clinical trial for the treatment of solid tumors. It has a collaboration agreement with Merck & Co. for clinical trials. The company was incorporated in 2007 and is based in Bergen, Norway.
Oslo Børs Benchmark Index_GI ended the session with BERGENBIO rising 12.13% to €0.34 on Thursday, after three consecutive sessions in a row of gains. Oslo Børs Benchmark Index_GI jumped 1.22% to €1,323.13, following the last session’s downward trend on what was an all-around up trend exchanging session today.
Earnings Per Share
As for profitability, BERGENBIO has a trailing twelve months EPS of kr-0.55.
Return on Equity
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -179.58%.
Volatility
BERGENBIO’s last week, last month’s, and last quarter’s current intraday variation average was 3.44%, 1.82%, and 6.97%.
BERGENBIO’s highest amplitude of average volatility was 3.44% (last week), 4.96% (last month), and 6.97% (last quarter).
More news about BERGENBIO.
2. NHOA (NHOA.PA)
10.06% Price Change
NHOA S.A. provides energy storage, E-mobility, and EV fastcharging infrastructure related solutions in France. The company offers solar plus storage, utility-scale storage, and industrial microgrids. It also provides charging services and devices for electric and hybrid vehicles. In addition, the company offers power house, and hybrid house; and HyESS, a technology platform for the transformation of renewables into sustainable grids, as well as Atlante, an eStation that provides fast charging solution. NHOA S.A. is based in Paris, France.
CAC 40 ended the session with NHOA rising 10.06% to €0.77 on Thursday while CAC 40 jumped 0.52% to €7,450.63.
Earnings Per Share
As for profitability, NHOA has a trailing twelve months EPS of €-1.9.
Return on Equity
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -94.09%.
Revenue Growth
Year-on-year quarterly revenue growth grew by 48.4%, now sitting on 203.51M for the twelve trailing months.
Volatility
NHOA’s last week, last month’s, and last quarter’s current intraday variation average was a positive 7.94%, a negative 0.08%, and a positive 2.67%.
NHOA’s highest amplitude of average volatility was 7.94% (last week), 2.75% (last month), and 2.67% (last quarter).
Yearly Top and Bottom Value
NHOA’s stock is valued at €0.77 at 21:40 EST, way below its 52-week high of €9.98 and way above its 52-week low of €0.59.
Volume
Today’s last reported volume for NHOA is 540484 which is 565.18% above its average volume of 81253.
More news about NHOA.
3. MEDIA CAPITAL (MCP.LS)
9.8% Price Change
Grupo Media Capital, SGPS, S.A. engages in the production and broadcasting of television and radio programs, and production and operation of cinematographic and video graphic activities in Portugal and internationally. It operates through Television, Radio & Entertainment, Audiovisual Production, and Others segments. The company broadcasts TVI, TVI 24, TVI Ficção, TVI Internacional, TVI Reality, and TVI Player channels. It is involved in the production, realization, and distribution of audiovisuals; and production of television programs for broadcasting in Portuguese language. The company operates Rádio Comercial, m80, Cidade FM, Smooth FM, and Vodafone FM radio stations; and 14 digital radios. It also operates iol.pt, an online directory of classified information; recording, publishing, events production, and artist management; and provides agency services for artists and promotion of events. The company is also involved in the provision of production support services; realization and development of television contents, cinema, and audiovisual works, as well as other related services; production of phonograms, audiovisual, and multimedia; purchase and sale of records and other items; and acquisition and distribution of cinematographic rights. Grupo Media Capital, SGPS, S.A. was incorporated in 1992 and is headquartered in Barcarena, Portugal.
PSI ended the session with MEDIA CAPITAL jumping 9.8% to €1.12 on Thursday, following the last session’s downward trend. PSI jumped 1.18% to €6,486.34, following the last session’s downward trend on what was an all-around up trend exchanging session today.
Earnings Per Share
As for profitability, MEDIA CAPITAL has a trailing twelve months EPS of €-0.11.
More news about MEDIA CAPITAL.
4. SAINT JEAN GROUPE (SABE.PA)
8.9% Price Change
Saint Jean Groupe Société anonyme, through its subsidiaries, operates in the agri-food sector in France. The company offers ravioles, dumplings, fresh pasta, and delicatessen products under the Saint, Royans, Ravioles de Romans, Quenelles La Royale, and Comptoir du Pastier brand names. The company is headquartered in Dardilly, France.
CAC 40 ended the session with SAINT JEAN GROUPE rising 8.9% to €20.80 on Thursday, following the last session’s downward trend. CAC 40 rose 0.52% to €7,450.63, after two consecutive sessions in a row of losses, on what was a somewhat up trend trading session today.
Earnings Per Share
As for profitability, SAINT JEAN GROUPE has a trailing twelve months EPS of €0.59.
PE Ratio
SAINT JEAN GROUPE has a trailing twelve months price to earnings ratio of 35.25. Meaning, the purchaser of the share is investing €35.25 for every euro of annual earnings.
Volume
Today’s last reported volume for SAINT JEAN GROUPE is 39 which is 98.57% below its average volume of 2735.
Dividend Yield
As claimed by Morningstar, Inc., the next dividend payment is on Jun 28, 2023, the estimated forward annual dividend rate is 0.1 and the estimated forward annual dividend yield is 0.48%.
Moving Average
SAINT JEAN GROUPE’s value is above its 50-day moving average of €20.63 and higher than its 200-day moving average of €19.98.
Revenue Growth
Year-on-year quarterly revenue growth grew by 16.5%, now sitting on 112.85M for the twelve trailing months.
More news about SAINT JEAN GROUPE.
5. INNATE PHARMA (IPH.PA)
8.73% Price Change
Innate Pharma S.A., a biotechnology company, develops immunotherapies for cancer patients in France and internationally. The company's products include Lacutamab (IPH4102), an anti-KIR3DL2 antibody, which is in Phase II clinical trials for the treatment of cutaneous T-cell and peripheral T-cell lymphoma, as well as in Phase II clinical trials to treat refractory sézary syndrome; Monalizumab, an immune checkpoint inhibitor that is in Phase III clinical trial to treat advanced solid tumors comprising colorectal and lung cancer, as well as head and neck cancer; Avdoralimab (IPH5401), an Anti-C5aR Antibody; IPH5201, a blocking antibody that is in Phase 1 clinical trials targeting the CD39 immunosuppressive pathway; IPH5301, an anti-CD73 antibody targeting the immunosuppressive adenosine pathway to promote antitumor immunity; IPH6401, an BCMA-targeting NK cell engager; and IPH6101, a NKp46-based NK cell engager that targets CD123 proprietary multi-specific antibody format; and IPH62, an B7-H3-targeting NK cell engager. Its products in preclinical trials are IPH43, an anti-MICA/B ADC and IPH4501, an antibody drug conjugates (ADC); and IPH65, a tetra-specific proprietary antibody. The company has licensing and collaboration agreements with AstraZeneca, Novo Nordisk A/S, Sanofi, and Orega Biotech; and co-development and license agreement with MedImmune Limited. Innate Pharma S.A. was incorporated in 1999 and is headquartered in Marseille, France.
CAC 40 ended the session with INNATE PHARMA jumping 8.73% to €2.74 on Thursday while CAC 40 rose 0.52% to €7,450.63.
Earnings Per Share
As for profitability, INNATE PHARMA has a trailing twelve months EPS of €-0.79.
Return on Equity
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -71.91%.
Yearly Top and Bottom Value
INNATE PHARMA’s stock is valued at €2.74 at 21:40 EST, way below its 52-week high of €3.80 and way above its 52-week low of €1.99.
Dividend Yield
As stated by Morningstar, Inc., the next dividend payment is on Jan 1, 1970, the estimated forward annual dividend yield is 4.64%.
Stock Price Classification
According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, INNATE PHARMA’s stock is considered to be overbought (>=80).
More news about INNATE PHARMA.
6. OCEANTEAM (OTS.OL)
8.65% Price Change
Oceanteam ASA operates as a subsea and offshore services company in Europe. It provides equipment for offshore cable laying, umbilical installations, and on- and offshore storage and transport. The company also rents turntables, tensioners, reels, demountable turntable systems, and other cable handling and storage equipment, as well as offers cable and umbilical storage, and handling solutions. It serves renewable energy, and oil and gas industries. The company was formerly known as Oceanteam Shipping ASA and changed its name to Oceanteam ASA in December 2015. Oceanteam ASA was incorporated in 2005 and is headquartered in Bærum, Norway.
Oslo Børs Benchmark Index_GI ended the session with OCEANTEAM jumping 8.65% to €1.45 on Thursday, after two successive sessions in a row of losses. Oslo Børs Benchmark Index_GI rose 1.22% to €1,323.13, following the last session’s downward trend on what was an all-around positive trend exchanging session today.
Earnings Per Share
As for profitability, OCEANTEAM has a trailing twelve months EPS of kr-0.3.
Return on Equity
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -13.62%.
More news about OCEANTEAM.
7. NANOBIOTIX (NANO.PA)
7.88% Price Change
Nanobiotix S.A., a clinical-stage biotechnology, focuses on developing product candidates for the treatment of cancer and other unmet medical needs. Its lead product candidate is NBTXR3, a sterile aqueous suspension of crystalline hafnium oxide nanoparticles used for the treatment of soft tissue sarcoma, head and neck cancers, liver cancers, prostate cancer, pancreatic cancer, esophageal cancer, rectal cancer, and non-small cell lung cancer. Nanobiotix S.A. has a partnership with Lian Oncology Limited to develop and commercialize NBTXR3 in Greater China, South Korea, Singapore, and Thailand. Nanobiotix S.A. was incorporated in 2003 and is headquartered in Paris, France.
CAC 40 ended the session with NANOBIOTIX jumping 7.88% to €7.12 on Thursday while CAC 40 jumped 0.52% to €7,450.63.
Earnings Per Share
As for profitability, NANOBIOTIX has a trailing twelve months EPS of €-1.68.
Yearly Top and Bottom Value
NANOBIOTIX’s stock is valued at €7.12 at 21:40 EST, way below its 52-week high of €10.40 and way above its 52-week low of €1.61.
Moving Average
NANOBIOTIX’s value is way higher than its 50-day moving average of €5.53 and way higher than its 200-day moving average of €5.74.
More news about NANOBIOTIX.
8. AVANCE GAS HOLDING (AGAS.OL)
6.92% Price Change
Avance Gas Holding Ltd, together with its subsidiaries, engages in the transportation of liquefied petroleum gas (LPG). The company transports LPG from the Persian Gulf and the United States Gulf/the United States East Coast to destinations in Europe, South America, India, and Asia. As of December 31, 2022, it owned and operated through a fleet of twelve very large gas carriers and four dual-fuel LPG newbuildings. The company was founded in 2007 and is based in Hamilton, Bermuda. Avance Gas Holding Ltd operates as a subsidiary of Hemen Holding Ltd.
Oslo Børs Benchmark Index_GI ended the session with AVANCE GAS HOLDING rising 6.92% to €170.00 on Thursday while Oslo Børs Benchmark Index_GI rose 1.22% to €1,323.13.
Earnings Per Share
As for profitability, AVANCE GAS HOLDING has a trailing twelve months EPS of kr18.16.
PE Ratio
AVANCE GAS HOLDING has a trailing twelve months price to earnings ratio of 9.36. Meaning, the purchaser of the share is investing kr9.36 for every norwegian krone of annual earnings.
Return on Equity
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 17.24%.
Volume
Today’s last reported volume for AVANCE GAS HOLDING is 216312 which is 6.9% above its average volume of 202338.
More news about AVANCE GAS HOLDING.
9. PLAST.VAL LOIRE (PVL.PA)
6.74% Price Change
Plastiques du Val de Loire engages in the production and sale of plastic parts in France, North America, and internationally. The company offers interior equipment for vehicles, such as cockpits, decoration products, and mechanisms; exterior appearance parts; technical front facades; seat parts; lighting and signaling products; and under the hood parts. It also manufactures plastic products for use in construction and electricity, household electrical appliances, multimedia, leisure and garden, and luxury/design markets. The company was founded in 1963 and is headquartered in Langeais, France.
CAC 40 ended the session with PLAST.VAL LOIRE rising 6.74% to €4.12 on Thursday while CAC 40 rose 0.52% to €7,450.63.
Earnings Per Share
As for profitability, PLAST.VAL LOIRE has a trailing twelve months EPS of €-1.47.
Return on Equity
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -4.52%.
Volume
Today’s last reported volume for PLAST.VAL LOIRE is 59516 which is 235.68% above its average volume of 17730.
Stock Price Classification
According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, PLAST.VAL LOIRE’s stock is considered to be oversold (<=20).
More news about PLAST.VAL LOIRE.
10. MEDINCELL (MEDCL.PA)
6.66% Price Change
MedinCell S.A., a pharmaceutical company, develops long acting injectables in various therapeutic areas in France. It develops solutions based on BEPO, a long-acting injectable technology. The company's products in development include mdc-IRM, a risperidone extended-release injectable suspension for use in the treatment of schizophrenia in adults; mdc-CWM, a sustained-release formulation of celecoxib in Phase III trials for use in the treatment of reduction of postoperative pain and inflammation; and mdc-TJK, a subcutaneous injection that is in Phase III clinical trials for use in the treatment of schizophrenia. Its product candidates in preclinical trials include mdc-ANG, an antipsychotic product for use in the treatment of schizophrenia; mdc-TTG for Covid-19 and its variants; mdc-GRT for organ transplant; mdc-WWM for contraception; mdc-STM for malaria; and mdc-IRM for neuroscience. MedinCell S.A. was incorporated in 2003 and is based in Jacou, France.
CAC 40 ended the session with MEDINCELL rising 6.66% to €7.37 on Thursday while CAC 40 rose 0.52% to €7,450.63.
Earnings Per Share
As for profitability, MEDINCELL has a trailing twelve months EPS of €-1.01.
Volume
Today’s last reported volume for MEDINCELL is 116484 which is 182.61% above its average volume of 41217.
More news about MEDINCELL.
Losers Today
1. CASINO GUICHARD (CO.PA)
-12.65% Price Change
Casino, Guichard-Perrachon S.A. operates as a food retailer in France, Latin America, and internationally. The company operates hypermarkets, supermarkets, shopping malls, and e-commerce sites, as well as convenience, discount, and cash and carry stores. It also involved in banking, digital marketing, service station, franchise, real estate asset management, property development and trading, rental, banking, and energy-related activities. It operates through stores. The company was founded in 1898 and is based in Saint-Étienne, France.Casino, Guichard-Perrachon S.A operates as a subsidiary of Rallye SA.
CAC 40 ended the session with CASINO GUICHARD dropping 12.65% to €0.65 on Thursday while CAC 40 rose 0.52% to €7,450.63.
Earnings Per Share
As for profitability, CASINO GUICHARD has a trailing twelve months EPS of €-20.53.
Return on Equity
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -65.71%.
Yearly Top and Bottom Value
CASINO GUICHARD’s stock is valued at €0.65 at 21:40 EST, way under its 52-week high of €12.17 and way above its 52-week low of €0.55.
Moving Average
CASINO GUICHARD’s value is way under its 50-day moving average of €0.84 and way under its 200-day moving average of €3.60.
Volatility
CASINO GUICHARD’s last week, last month’s, and last quarter’s current intraday variation average was a negative 2.51%, a positive 1.82%, and a positive 5.24%.
CASINO GUICHARD’s highest amplitude of average volatility was 2.51% (last week), 6.51% (last month), and 5.24% (last quarter).
Stock Price Classification
According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, CASINO GUICHARD’s stock is considered to be overbought (>=80).
More news about CASINO GUICHARD.
2. SCHEERD.V KERCHOVE (SCHD.BR)
-10% Price Change
Scheerders van Kerchove's Verenigde fabrieken nv manufactures and distributes building materials. It offers façade panels, slates, facing bricks, and corrugated sheets. The company was founded in 1905 and is based in Sint-Niklaas, Belgium.
BEL 20 ended the session with SCHEERD.V KERCHOVE dropping 10% to €414.00 on Thursday while BEL 20 rose 1% to €3,721.89.
Earnings Per Share
As for profitability, SCHEERD.V KERCHOVE has a trailing twelve months EPS of €-2.58.
Return on Equity
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -15.06%.
More news about SCHEERD.V KERCHOVE.
3. ADOCIA (ADOC.PA)
-8.7% Price Change
Adocia SA, a clinical-stage biotechnology company, researches and develops formulations of pre-approved therapeutic proteins and peptides for the treatment of diabetes and other metabolic diseases. Its proprietary BioChaperone technological platform provides molecular delivery of therapeutic proteins. The company's clinical product pipeline includes insulin formulations, such as BioChaperone Lispro U100 and U200, which are ultra-rapid formulations based on rapid insulin lispro; BioChaperone Combo, a combination of acting insulin glargine and rapid-acting insulin lispro; BioChaperone LisPram, a combination of prandial insulin with pramlintide; and BioChaperone Glucagon, an aqueous formulation of human glucagon for the treatment of hypoglycemia, as well as M1Pram, a metabolite of insulin glargine and pramlintide. Its preclinical pipeline includes products for the treatment of diabetes and obesity comprising AdoShell Islets, an implant containing islets of Langerhans; AdOral Sema, an oral delivery of semaglutide; and BioChaperone GluExe, a combination of glucagon and exenatide. The company has a strategic alliance with Tonghua Dongbao Pharmaceutical Co., Ltd. to develop and commercialize BioChaperone Lispro and BioChaperone Combo in China and other Asian and Middle Eastern territories. Adocia SA was incorporated in 2005 and is headquartered in Lyon, France.
CAC 40 ended the session with ADOCIA dropping 8.7% to €10.28 on Thursday, following the last session’s downward trend. CAC 40 rose 0.52% to €7,450.63, after two successive sessions in a row of losses, on what was a somewhat up trend trading session today.
Earnings Per Share
As for profitability, ADOCIA has a trailing twelve months EPS of €-2.5.
Moving Average
ADOCIA’s worth is way above its 50-day moving average of €8.50 and way above its 200-day moving average of €6.29.
Revenue Growth
Year-on-year quarterly revenue growth declined by 62.6%, now sitting on 10.84M for the twelve trailing months.
More news about ADOCIA.
4. RALLYE (RAL.PA)
-7.91% Price Change
Rallye SA, together with its subsidiaries, engages in the food and non-food e-commerce retailing business in France and internationally. The company operates in two segments, Food and General Retailing, and Holdings and Other Activities. It operates hypermarkets, supermarkets, and convenience stores. The company conducts its retailing activities in France primarily under the Casino, Monoprix, and Franprix banners; food retail activities in Brazil, Colombia, Uruguay, and Argentina mainly under the GPA food banners, Éxito, Disco-Devoto, and Libertad banners; and e-commerce comprising Cdiscount and the Cnova N.V. holding company businesses. It is also involved in the financial investment, property development, and energy related activities. The company was founded in 1925 and is headquartered in Paris, France. Rallye SA operates as a subsidiary of Foncière Euris SA.
CAC 40 ended the session with RALLYE sliding 7.91% to €0.12 on Thursday, following the last session’s upward trend. CAC 40 jumped 0.52% to €7,450.63, after two consecutive sessions in a row of losses, on what was a somewhat positive trend exchanging session today.
Earnings Per Share
As for profitability, RALLYE has a trailing twelve months EPS of €-12.91.
Return on Equity
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -71.26%.
Volume
Today’s last reported volume for RALLYE is 221122 which is 85.75% below its average volume of 1552200.
Moving Average
RALLYE’s worth is way under its 50-day moving average of €0.14 and way below its 200-day moving average of €0.69.
Volatility
RALLYE’s last week, last month’s, and last quarter’s current intraday variation average was a negative 0.23%, a negative 1.43%, and a positive 10.24%.
RALLYE’s highest amplitude of average volatility was 0.98% (last week), 3.63% (last month), and 10.24% (last quarter).
More news about RALLYE.
5. PIERRE VAC BSA ACT (VACBS.PA)
-7.04% Price Change
CAC 40 ended the session with PIERRE VAC BSA ACT dropping 7.04% to €0.13 on Thursday, after consecutive sessions in a row of losses. CAC 40 rose 0.52% to €7,450.63, after two consecutive sessions in a row of losses, on what was a somewhat positive trend exchanging session today.
Yearly Top and Bottom Value
PIERRE VAC BSA ACT’s stock is valued at €0.13 at 21:40 EST, way under its 52-week low of €0.16.
More news about PIERRE VAC BSA ACT.
6. DGB GROUP N.V. (DGB.AS)
-5.1% Price Change
DGB Group N.V. invests in, develops, and manages biodiversity and carbon offset, and nature-based projects for businesses and governments in the Netherlands and internationally. The company offers nature-based solutions comprising the management and use of nature for tackling social and environmental challenges; carbon offsetting projects for reducing carbon footprint of companies; and biodiversity protection and ecosystem services. It also provides ESG reporting and tree integration services. The company was formerly known as Verenigde Nederlandse Compagnie N.V. and changed its name to DGB Group N.V. in January 2018. DGB Group N.V. was founded in 1957 and is based in Haarlemmermeer, the Netherlands.
AEX-Index ended the session with DGB GROUP N.V. sliding 5.1% to €0.47 on Thursday while AEX-Index rose 0.07% to €780.31.
Earnings Per Share
As for profitability, DGB GROUP N.V. has a trailing twelve months EPS of €-0.15.
Moving Average
DGB GROUP N.V.’s worth is above its 50-day moving average of €0.47 and way under its 200-day moving average of €0.53.
Yearly Top and Bottom Value
DGB GROUP N.V.’s stock is valued at €0.47 at 21:40 EST, way below its 52-week high of €1.04 and way above its 52-week low of €0.38.
More news about DGB GROUP N.V..
7. GEA GRENOBL.ELECT. (GEA.PA)
-5% Price Change
Grenobloise d'Electronique et d'Automatismes Société Anonyme designs, develops, manufactures, integrates, installs, and maintains electronic and computerized toll collection systems. Its products include automatic ticket issuing machines, manual toll terminals, automatic payment machines, plaza computer and central systems, non-stop toll collection systems, and manual or automatic entry and exit lanes. The company also designs car park revenue control systems, such as entry lane terminals, restricted entry lane terminals, exit lane terminals, pedestrian access control terminals, automatic payment machines, manual payment machines, car park management supervision servers, and central computer systems. In addition, it offers electronic toll collection equipment comprising roadside beacons for mono or multilane applications; on-board units; and desktop reader encoders. It serves various motorway companies in Europe, Asia, the Middle East, North Africa, Central America, South America, and the Caribbean Islands. Grenobloise d'Electronique et d'Automatismes Société Anonyme was incorporated in 1971 and is based in Meylan, France.
CAC 40 ended the session with GEA GRENOBL.ELECT. falling 5% to €95.00 on Thursday while CAC 40 rose 0.52% to €7,450.63.
Earnings Per Share
As for profitability, GEA GRENOBL.ELECT. has a trailing twelve months EPS of €1.93.
PE Ratio
GEA GRENOBL.ELECT. has a trailing twelve months price to earnings ratio of 49.22. Meaning, the purchaser of the share is investing €49.22 for every euro of annual earnings.
Return on Equity
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 2.94%.
Volume
Today’s last reported volume for GEA GRENOBL.ELECT. is 1591 which is 5032.26% above its average volume of 31.
Dividend Yield
As claimed by Morningstar, Inc., the next dividend payment is on Apr 5, 2023, the estimated forward annual dividend rate is 1.3 and the estimated forward annual dividend yield is 1.29%.
More news about GEA GRENOBL.ELECT..
8. CNOVA (CNV.PA)
-5% Price Change
Cnova N.V. operates as an e-commerce company in France and Western Europe. The company offers home appliances, consumer electronics, computers, home furnishings, and leisure and personal goods through its cdiscount.com website. It also operates Cdiscount Voyages, a travel platform; Cdiscount Mobile for cell phone plans; Cdiscount Advertising, a digital marketing solution; Octopia for turnkey marketplace solutions to retailers and e-merchants; and C-Logistics for transportation and logistics services. The company was founded in 1998 and is headquartered in Amsterdam, the Netherlands. Cnova N.V. is a subsidiary of Casino, Guichard-Perrachon S.A.
CAC 40 ended the session with CNOVA falling 5% to €1.90 on Thursday while CAC 40 jumped 0.52% to €7,450.63.
Earnings Per Share
As for profitability, CNOVA has a trailing twelve months EPS of €-0.35.
Volume
Today’s last reported volume for CNOVA is 3685 which is 318.75% above its average volume of 880.
More news about CNOVA.
9. BE SEMICONDUCTOR (BESI.AS)
-4.71% Price Change
BE Semiconductor Industries N.V. engages in the development, manufacture, marketing, sale, and service of semiconductor assembly equipment for the semiconductor and electronics industries worldwide. The company's principal products include die attach equipment, such as single chip, multi-chip, multi module, flip chip, thermal compression bonding, fan out wafer level packaging, hybrid and embedded bridge die bonding, and die sorting systems; and packaging equipment, including conventional, ultra-thin, and wafer level molding, as well as trim and form, and singulation systems. Its principal products also comprise plating equipment, such as tin, copper, and precious metal and solar plating systems, as well as related process chemicals; and tooling, conversion kits, spare parts, and other services. The company's principal brand names include Datacon, Esec, Fico, and Meco. It offers its products primarily to multinational chip manufacturers, assembly subcontractors, and electronics and industrial companies. The company was incorporated in 1995 and is headquartered in Duiven, the Netherlands.
AEX-Index ended the session with BE SEMICONDUCTOR falling 4.71% to €124.45 on Thursday, after four sequential sessions in a row of losses. AEX-Index rose 0.07% to €780.31, after three successive sessions in a row of losses, on what was a somewhat up trend trading session today.
Earnings Per Share
As for profitability, BE SEMICONDUCTOR has a trailing twelve months EPS of €2.04.
PE Ratio
BE SEMICONDUCTOR has a trailing twelve months price to earnings ratio of 61. Meaning, the purchaser of the share is investing €61 for every euro of annual earnings.
Return on Equity
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 31.43%.
Stock Price Classification
According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, BE SEMICONDUCTOR’s stock is considered to be overbought (>=80).
Volume
Today’s last reported volume for BE SEMICONDUCTOR is 362498 which is 10.73% below its average volume of 406099.
More news about BE SEMICONDUCTOR.
10. ATOS (ATO.PA)
-4.68% Price Change
Atos SE provides digital transformation solutions and services worldwide. It offers advanced computing solutions; analytics, artificial intelligence, and automation solutions; cloud solutions; customer journey analytics and digital customer experience; decarbonization solutions; digital consulting; digital workplace solutions; edge computing and Internet of things solutions; and modern applications and platforms. The company also provides advance detection and response, data protection and governance, digital workplace security, IoT and OT security, trusted digital identities, and cybersecurity solutions; and infrastructure and foundation services. It serves financial services and insurance, healthcare and life sciences, manufacturing, public sector and defense, resources and services, telecom, media, and entertainment industries. The company was incorporated in 1982 and is headquartered in Bezons, France.
CAC 40 ended the session with ATOS sliding 4.68% to €6.28 on Thursday while CAC 40 rose 0.52% to €7,450.63.
Earnings Per Share
As for profitability, ATOS has a trailing twelve months EPS of €-10.01.
More news about ATOS.
Stay up to date with our winners and losers daily report
